Visudyne Related Clinical Trials
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Recruiting]
Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) [Terminated]
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) [Active, not recruiting]
Visudyne® in Occult (VIO) [Completed]
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-Based Retreatment [Recruiting]
VERITAS: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Active, not recruiting]
Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration [Completed]
Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD [Recruiting]
Photodynamic and Pharmacologic Treatment of CNV [Active, not recruiting]
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy [Recruiting]
Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. [Not yet recruiting]
Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD [Recruiting]
Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration [Recruiting]
The Avastin vs Visudyne for Neovascular AMD Study [Withdrawn]
Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD [Completed]
Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Recruiting]
Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy [Recruiting]
Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV [Active, not recruiting]
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy [Recruiting]
Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC) [Completed]
Two Studies to Determine If Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. [Terminated]
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Recruiting]
Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD [Recruiting]
Second Line Therapy to Treat Age-Related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself [Available]
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration [Completed]
Efficacy and Safety of Verteporfin Photodynamic Therapy Administered With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Recruiting]
Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis [Recruiting]
Photodynamic Therapy in Occult-Only Lesions (POOL) [Completed]
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD) [Completed]
Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration [Recruiting]
Photodynamic Therapy With Verteporfin for Corneal Neovascularization [Completed]
Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration [Completed]
Phase 3 Study to Evaluate Anecortave Acetate Vs. Visudyne for the Treatment of the Wet Form of AMD. [Active, not recruiting]
Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB) [Active, not recruiting]
Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration [Active, not recruiting]
A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes [Not yet recruiting]
Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration [Not yet recruiting]
Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy [Not yet recruiting]
VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration) [Recruiting]
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD [Recruiting]
Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-Related Macular Degeneration (AMD) [Recruiting]
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration [Recruiting]
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains [Enrolling by invitation]
MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) [Terminated]
Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization [Recruiting]
Treatment of Age-Related Macular Degeneration With Anecortave Acetate [Active, not recruiting]
PDT Study for Exudative AMD With PCV [Active, not recruiting]
Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) [Active, not recruiting]
Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) [Recruiting]
Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration [Completed]
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors [Recruiting]
Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD [Recruiting]
Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma [Active, not recruiting]
Ranibizumab and Reduced Fluence PDT for AMD [Recruiting]
TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration [Terminated]
The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot [Recruiting]
Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy [Completed]
Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD. [Active, not recruiting]
Combination Therapy for Age-Related Macular Degeneration. [Recruiting]
Macugen for Histoplasmosis [Terminated]
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care. [Completed]
The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy [Recruiting]
Avastin for CNV Secondary to Pattern Dystrophy [Recruiting]
Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)
Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Recruiting]
Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
Retaane® in Age-Related Macular Degeneration
|
